KHSC expands liver cancer treatment with cutting-edge Y90 therapy
Kingston Health Sciences Centre (KHSC) is now home to one of the most advanced treatments for liver cancer in Canada....
liver
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment...
Liver Cancer Treatment Market to Reach $12.88 Billion by 2033,
Liver Cancer Treatment MarketLiver Cancer Treatment Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market...
80 Nurses Rally to Save Baby Girl Who Needed Liver Transplant
Nine-month-old Mattie Beacham was in a coma; her organs were shutting down, and her little body was fighting a battle...
Unlocking a new era in liver cancer treatment: The power of neddylation-targeted therapies
image: Neddylation drives liver disease to induce the development of hepatocellular carcinoma. Image link: view more Credit: Genes...
Taiwan researchers unveil safer strategy for liver cancer treatment
Taipei, May 3 (CNA) Medical researchers from National Taiwan University Hospital (NTUH) and Taipei Medical University (TMU) presented key findings...
